Brazil TFVS Fee Mechanism under Lei No. 9.782/1999: Subject Codes and Company Size

1. Key takeaways

The health surveillance fee (TFVS, Taxa de Fiscalização de Vigilância Sanitária) is not a fixed charge: its amount is determined jointly by the application matter code and company size (Porte da Empresa). It was created by Article 23 of Lei n° 9.782/1999 (published January 26, 1999), and the current collection procedure is set by RDC n° 857/2024 — published May 9, 2024, effective June 3, 2024.

GRZAN’s judgment: treating the TFVS as a minor miscellaneous cost is the most common budgeting error. It is a statutory levy that recurs with every review matter filed to ANVISA, and it cannot be estimated as a one-time bundle.

2. Legal basis

• Establishment of the National Health Surveillance Agency and the Brazilian national health surveillance system — Lei n° 9.782/1999, published January 26, 1999, Articles 7, 15 and 23 (creation of the TFVS and reduction rules) [official text of Lei 9.782/1999 not obtained this round; article content follows standard industry compilation, subject to publication on Planalto]
• TFVS collection procedure — RDC n° 857/2024, published May 9, 2024 and effective June 3, 2024, provisions on company economic-capacity review and GRU payment
• Basic law on sanitary oversight of health products — Lei n° 6.360/1976, published September 23, 1976, Article 82
• Brazilian sanitary violations and penalties law — Lei n° 6.437/1977, signed August 20, 1977, DOU August 24, 1977 (Seção 1, p. 11145), fine range of BRL 2,000–1,500,000

3. Expert insights

The design logic of the TFVS is charge per matter, calibrated by capacity. Being a statutory levy, the legislation does not allow the agency to price at discretion; instead the variables sit on two objective dimensions: what is being applied for (the application matter code) and who is applying (the company size review). The direct consequence is that the same technical dossier generates different fees under companies of different sizes — and which group entity acts as applicant is itself a cost that can be computed in advance.

The first pitfall is inaccurate size declaration. RDC n° 857/2024 consolidated the TFVS fee rules with the company economic-capacity review; a size determination inconsistent with reality carries clawback risk, and group structure, revenue basis and their relation to the local entity must be unified before filing.

The second pitfall is missing items. Change applications, site changes, import-stage licenses and post-filing responses each trigger their own matter; a budget that counts only the initial registration will not suffice. [practical estimate, subject to ANVISA publication]

The third pitfall is payment channeling. The declaration and payment channels for the import stage are in adjustment, and specific batches and timing must follow ANVISA and DOU publications — do not schedule processes on the old channels before landing. [practical estimate, subject to ANVISA publication]

In project costing GRZAN also isolates two variables: company size (Porte da Empresa) is graded as Grupo I–IV, EPP and ME with proportional reductions attached, while the application matter code has a single authoritative lookup — ANVISA’s Consulta de Assuntos (consultas.anvisa.gov.br). The former sets the discount, the latter sets the base, and their product is the amount due. Any quotation that does not state both variables is unusable for budgeting, no matter how it frames the question of what registration costs.

Add the statutory chain: the TFVS rests on Article 23 of Lei n° 9.782/1999, while charging for public services traces up to Article 82 of Lei n° 6.360/1976; RDC n° 857/2024 (resolution of May 9, 2024, effective June 3, 2024) consolidated prior fee rules, the economic-capacity review and GRU payment into one procedure. The payment channel itself is switching tracks: import declarations are migrating from LI/LPCO to DUIMP, with TFVS payment folded into the foreign trade single portal PCCE. GRZAN’s advice is to confirm the channel per the current official position when scheduling, rather than locking the operations manual to old channels.

A fourth cognitive bias is conflating the TFVS with fines. Their legal natures are entirely different: the former is a levy; the latter falls under Lei n° 6.437/1977, with fines set by violation severity (leve / grave / gravíssima), exact amounts governed by current rules [the original amounts in Article 5 of Lei 6.437/1977 were denominated in 1977 cruzeiros, no longer legal tender after repeated currency changes; this series does not list amounts], alongside seizure, sales bans and cancellation of marketing authorization. Mixing them in one account both corrupts the budget and muddies the scope of paid matters when inspected.

The last easily missed dimension is time. Amounts adjust with the fiscal year, so the same matter filed in different years costs differently; every written quotation should state its validity and the query date, and paying the TFVS never excuses non-compliance. GRZAN asks ANVISA in advance how withdrawn or inadmissible matters are handled — far cheaper than arguing afterward.

4. Practical recommendations

• Split the budget sheet by application matter code times occurrences, noting the code and payment basis on each line.
• Prepare size evidence early and unify the determination basis at group level.
• Estimate fee impact of planned changes in advance, including site, label, IFU and grouping adjustments.
• Use the ANVISA site and its regulatory library (gov.br/anvisa) for official queries; obtain GRU payment slips only through official channels, with the amount as computed by the system at issuance.
• Keep TFVS and fines under Lei n° 6.437/1977 in separate accounts.
• Archive every GRU against its matter number for later self-verification.
• State on written quotations that the amount follows ANVISA system calculation at filing date, with the query date marked, to prevent cross-year budget drift.

5. Verification checklist

• □ Creation of the TFVS has been confirmed as Article 23 of Lei n° 9.782/1999
• □ The current collection procedure has been confirmed as RDC n° 857/2024 (effective June 3, 2024)
• □ The matter code of each application has been entered in the budget sheet
• □ Company size (Porte da Empresa) evidence is complete and consistently determined
• □ Current GRU amounts have been checked through ANVISA official channels

Regulatory information verified as of October 29, 2026.

GRZAN Regulatory Team

GRZAN provides registration and compliance support for medical device and IVD manufacturers entering the Brazilian market, covering TFVS budgeting and matter-code mapping, ANVISA fee procedures, registration dossier preparation and post-market compliance. For assistance with Brazilian regulatory requirements, contact info@grzanglobal.com.